Researchers have suggested that uniform evidence standards and reporting requirements could help speed patient access to cell ...

Drug development is an expensive and high-risk process. The median cost per approved drug can reach up to $2.8 billion, ...

Massachusetts General Hospital coordinated the first four platform trials within the HEALEY ALS platform to evaluate ...

Conclusions Based on our LCAs of seven clinical trials spanning all four phases of development and multiple disease areas, there are five activities that drive no less than 79% of the average clinical ...

A groundbreaking study led by researchers at Insilico Medicine has revealed the potential of TNIK inhibition as an innovative ...

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for ...

Elisa Cascade, CPO at Advarra explains why addressing the challenges faced by clinical research sites is vital for improving patient trust and the overall viability of clinical trials.

Clinical trial complexity has significantly increased in the past decade. How can the industry adapt and innovate to remain ...

In this digital era, Vamsi Upputuri, a leading expert in regulatory automation, explores cutting-edge advancements in ...

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Feb. 18, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address ...

Machine learning can help investors dive deeper into trial data to evaluate the true potential of an asset and uncover new ...

Carrillo, MD, a postdoctoral fellow at City of Hope Comprehensive Cancer Center, discussed findings that show 76% of renal ...